Global Glucuronolactone Sales Market Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Glucuronolactone Sales Market Report 2024
Market Analysis and InsightsGlobal Glucuronolactone Market
Glucuronolactone is a naturally occurring substance that is an important structural component of nearly all connective tissues.Glucuronolactone is also found in many plant gums.
Due to the COVID-19 pandemic, the global Glucuronolactone market size is estimated to be worth US$ 253.4 million in 2024 and is forecast to a readjusted size of US$ 333.8 million by 2034 with a CAGR of 4.0% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Medical accounting for % of the Glucuronolactone global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.
The United States Glucuronolactone market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Glucuronolactone include Ceto Corporation, Anhui Fubore Pharmaceutical & Chemical, Creative Compounds, Foodchem International, Hubei Yitai Pharmaceutical, Merck Millipore, Shaoxing Marina Biotechnology, Shouguang Zhonghe Biochemical and Suzhou Pharmaceutical Group, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Glucuronolactone Scope and Market Size
The global Glucuronolactone market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Glucuronolactone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Medical
Food
Pharmaceuticals
Food & Beverage
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
Ceto Corporation
Anhui Fubore Pharmaceutical & Chemical
Creative Compounds
Foodchem International
Hubei Yitai Pharmaceutical
Merck Millipore
Shaoxing Marina Biotechnology
Shouguang Zhonghe Biochemical
Suzhou Pharmaceutical Group
Glucuronolactone is a naturally occurring substance that is an important structural component of nearly all connective tissues.Glucuronolactone is also found in many plant gums.
Due to the COVID-19 pandemic, the global Glucuronolactone market size is estimated to be worth US$ 253.4 million in 2024 and is forecast to a readjusted size of US$ 333.8 million by 2034 with a CAGR of 4.0% during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Medical accounting for % of the Glucuronolactone global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.
The United States Glucuronolactone market is estimated at US$ million in 2024, while China was US$ million. The proportion of the United States is % in 2024, while Chinese percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period.
The global key manufacturers of Glucuronolactone include Ceto Corporation, Anhui Fubore Pharmaceutical & Chemical, Creative Compounds, Foodchem International, Hubei Yitai Pharmaceutical, Merck Millipore, Shaoxing Marina Biotechnology, Shouguang Zhonghe Biochemical and Suzhou Pharmaceutical Group, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In United States, in terms of sales revenue, in 2024, the top three players hold a share about %, while in China, top three players hold a share nearly %.
Global Glucuronolactone Scope and Market Size
The global Glucuronolactone market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Glucuronolactone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2034.
Segment by Type
Medical
Food
Segment by Application
Pharmaceuticals
Food & Beverage
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Ceto Corporation
Anhui Fubore Pharmaceutical & Chemical
Creative Compounds
Foodchem International
Hubei Yitai Pharmaceutical
Merck Millipore
Shaoxing Marina Biotechnology
Shouguang Zhonghe Biochemical
Suzhou Pharmaceutical Group